| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |